Semaglutide 2.4 mg/wk for Weight Loss in Patients with Severe Obesity and with or without a History of Bariatric Surgery

Bonnet JB, Tournayre S, Anitcheou J, Faivre M, Boegner C, Jalek A, Jullien D, Attalin V, Myzia J, Marty L, Kemba Y, Nocca D, Sultan A, Avignon A. Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery. Obesity (Silver Spring). 2023 Nov 5. PMID: 37927153.

Abstrak